Home >> Pharmaceuticals >> Food & Beverage >>

Amura Holdings Ltd. - Product Pipeline Review - 2015

Published: Apr-2015 | Format: PDF | Global Markets Direct | Number of pages: 22 | Code: MRS - 18285

Amura Holdings Ltd. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Amura Holdings Ltd. - Product Pipeline Review - 2015’, provides an overview of the Amura Holdings Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Amura Holdings Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Amura Holdings Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Amura Holdings Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Amura Holdings Ltd.’s pipeline products

Reasons to buy

- Evaluate Amura Holdings Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Amura Holdings Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Amura Holdings Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Amura Holdings Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Amura Holdings Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Amura Holdings Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Amura Holdings Ltd. Snapshot 4
Amura Holdings Ltd. Overview 4
Key Information 4
Key Facts 4
Amura Holdings Ltd. - Research and Development Overview 5
Key Therapeutic Areas 5
Amura Holdings Ltd. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Amura Holdings Ltd. - Pipeline Products Glance 9
Amura Holdings Ltd. - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Amura Holdings Ltd. - Drug Profiles 10
AM-112 10
Product Description 10
Mechanism of Action 10
R&D Progress 10
AM-3701 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
AM-3840 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
AM-3876 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Small Molecules to Inhibit Cathepsin for Malaria 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Amura Holdings Ltd. - Pipeline Analysis 15
Amura Holdings Ltd. - Pipeline Products by Target 15
Amura Holdings Ltd. - Pipeline Products by Route of Administration 16
Amura Holdings Ltd. - Pipeline Products by Molecule Type 17
Amura Holdings Ltd. - Pipeline Products by Mechanism of Action 18
Amura Holdings Ltd. - Dormant Projects 19
Amura Holdings Ltd. - Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
Coverage 21
Secondary Research 21
Primary Research 21
Expert Panel Validation 21
Contact Us 21
Disclaimer 22

List of Tables
Amura Holdings Ltd., Key Information 4
Amura Holdings Ltd., Key Facts 4
Amura Holdings Ltd. - Pipeline by Indication, 2015 6
Amura Holdings Ltd. - Pipeline by Stage of Development, 2015 7
Amura Holdings Ltd. - Monotherapy Products in Pipeline, 2015 8
Amura Holdings Ltd. - Preclinical, 2015 9
Amura Holdings Ltd. - Pipeline by Target, 2015 15
Amura Holdings Ltd. - Pipeline by Route of Administration, 2015 16
Amura Holdings Ltd. - Pipeline by Molecule Type, 2015 17
Amura Holdings Ltd. - Pipeline Products by Mechanism of Action, 2015 18
Amura Holdings Ltd. - Dormant Developmental Projects,2015 19
Amura Holdings Ltd., Other Locations 20
Amura Holdings Ltd., Subsidiaries 20

List of Figures
Amura Holdings Ltd. - Pipeline by Top 10 Indication, 2015 6
Amura Holdings Ltd. - Pipeline by Top 10 Target, 2015 15
Amura Holdings Ltd. - Pipeline by Top 10 Route of Administration, 2015 16
Amura Holdings Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015 18

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing